Manual Resuscitator Market is estimated to reach a startling USD 1,204.3 Million, at a consistent 6.4% CAGR by 2034 | FMI

The critical role of manual resuscitators in saving lives is driving substantial growth in the market. According to a recent analysis, the Manual Resuscitator Market is currently valued at USD 647.6 million and is poised for significant expansion. The market is projected to reach a staggering USD 1,204.3 million by 2034, reflecting a steady Compound …

Manual Resuscitator Market to Reach US$845.3 Million by 2030, Fueled by Rising COPD Cases

The Manual Resuscitator Market, critical for providing emergency respiratory support, is poised for steady growth. According to a recent market study by Future Market Insights (FMI), a leading ESOMAR-certified market research company, the industry is projected to reach a valuation of US$845.3 million by 2030. This upward trajectory is primarily driven by the concerning rise …

Global Manual Resuscitator Industry Expected to Reach US$845.3 Million by 2030, Driven by Rising COPD Cases

The Global Manual Resuscitator Industry is projected to reach a valuation of US$845.3 million by 2030, according to a recent market study by Future Market Insights (FMI), a leading ESOMAR-certified market research company. This growth is attributed to the concerning rise in Chronic Obstructive Pulmonary Disease (COPD) cases worldwide. COPD: Fueling the Demand for Manual …

Global Manual Resuscitator Industry Set to Reach US$ 845.3 Million, Driven by 5.7% CAGR | Reveals by FMI

In a groundbreaking study conducted by Future Market Insights (FMI), the Global Manual Resuscitator Industry is set for unprecedented expansion, with an anticipated valuation of US$ 845.3 million by the year 2030. The ESOMAR-certified research, spearheaded by FMI, highlights the pivotal role of manual resuscitation in addressing breathlessness, a primary symptom of Chronic Obstructive Pulmonary …

Global Manual Resuscitator Industry on an Upward Trajectory, Forecasted to Hit US$ 845.3 Million by 2030 at 5.7% CAGR | FMI

According to research by ESOMAR-certified company Future Market Insights, the Global Manual Resuscitator Industry is expected to reach a valuation of US$ 845.3 million by 2030. (FMI). in a recent market research. Breathlessness is the first symptom of COPD (chronic obstructive pulmonary disease), one of the most serious diseases. According to the WHO, the number of …

Global Manual Resuscitator Industry Poised to Reach USD 845.3 Million by 2030, | Reveals FMI

The Global Manual Resuscitator Industry is expected to witness remarkable growth, reaching a valuation of USD 845.3 million by the year 2030, according to a comprehensive study conducted by Future Market Insights (FMI), an ESOMAR-certified market research company. Breathlessness, often the first symptom of Chronic Obstructive Pulmonary Disease (COPD), a severe and prevalent respiratory condition, …

Global Manual Resuscitator Industry Set to Reach USD 845.3 Million by 2030 with a Remarkable 5.7% CAGR | FMI

The Global Manual Resuscitator Industry, as indicated by recent research conducted by ESOMAR-certified firm Future Market Insights (FMI), is anticipated to achieve a valuation of USD 845.3 million by the year 2030. Breathlessness, a primary symptom of Chronic Obstructive Pulmonary Disease (COPD), a severe respiratory ailment, has become an increasing concern worldwide. According to the …

Manual Resuscitator Market 2020 Outlook, Current and Future Industry Landscape Analysis 2030

The global manual resuscitator market is set to surpass a valuation of USD 500 million by 2030, according to a research by ESOMAR-certified firm Future Market Insights (FMI). In a new study on the market, the COPD (chronic obstructive pulmonary disease) is amongst the most life-threatening diseases, wherein breathlessness forms the very first symptom. The WHO states …

Manual Resuscitator Market expected at a CAGR of ~ 4.1% & US$ 23.6 Mn during the forecast period 2020–2030

The global manual resuscitator market is set to surpass a valuation of USD 500 million by 2030, according to a research by ESOMAR-certified firm Future Market Insights (FMI). In a new study on the market, the COPD (chronic obstructive pulmonary disease) is amongst the most life-threatening diseases, wherein breathlessness forms the very first symptom. The WHO …